ALI USMANI

Allopathic & Osteopathic Physicians|Internal Medicine|Interventional Cardiology MIDDLETOWN, OH NPI 1013968817

General Payments — all program years on this page

$3,494.46

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 67
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $448.44 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $448.4419

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $447.3411
2019 $905.2010
2020 $598.497
2021 $262.626
2022 $637.835
2023 $194.549
2024 $448.4419

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078132131 Janssen Pharmaceuticals, Inc $15.73 05/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078132169 Janssen Pharmaceuticals, Inc $21.75 06/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078132189 Janssen Pharmaceuticals, Inc $14.39 01/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1080558051 ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $19.88 01/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1081714346 Lexicon Pharmaceuticals, Inc. $15.37 08/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087436344 Novartis Pharmaceuticals Corporation $24.70 08/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087436366 Novartis Pharmaceuticals Corporation $14.79 10/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087436368 Novartis Pharmaceuticals Corporation $28.87 11/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087436372 Novartis Pharmaceuticals Corporation $13.29 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092502938 Boston Scientific Corporation $13.66 08/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096601577 Novo Nordisk Inc $19.57 05/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101581737 E.R. Squibb & Sons, L.L.C. $14.27 09/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117838965 Boehringer Ingelheim Pharmaceuticals, Inc. $18.38 09/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117838967 Boehringer Ingelheim Pharmaceuticals, Inc. $22.53 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132283380 SCPHARMACEUTICALS INC. $19.79 06/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141760153 Merck Sharp & Dohme LLC $28.02 07/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1152382014 Kestra Medical Technology Services, Inc. $100.10 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1152382016 Kestra Medical Technology Services, Inc. $23.42 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154868834 Kiniksa Pharmaceuticals International, plc $19.93 08/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.